D116 Unit 8 Study Guide
Student Name
Western Governors University
D116 Advanced Pharmacology for the Advanced Practice Nurse
Prof. Name
Date
Unit 8 Study Guide
What are adverse reactions and interactions with muscarinic agonists?
Muscarinic agonists are pharmacologic agents that stimulate muscarinic receptors within the parasympathetic nervous system. A commonly prescribed example is bethanechol, which is frequently used to manage urinary retention and gastrointestinal motility disorders. Due to its mechanism of action, bethanechol produces widespread parasympathetic effects that may lead to clinically significant adverse reactions.
Cardiovascular effects include hypotension, resulting from peripheral vasodilation, and bradycardia caused by increased vagal tone. Gastrointestinal adverse effects are also common and include excessive salivation, increased gastric acid secretion, abdominal cramping, nausea, and diarrhea. These effects are a direct consequence of heightened smooth muscle activity and glandular secretion.
Respiratory complications are particularly concerning in patients with reactive airway disease. Muscarinic agonists may precipitate bronchoconstriction and increased bronchial secretions, thereby worsening asthma or chronic obstructive pulmonary disease. Because of these risks, muscarinic agonists should be used cautiously in individuals with cardiovascular disease, gastrointestinal obstruction, or pulmonary disorders.
If patients continue to be re-infected with UTIs, what medication prophylaxis should be given? Differentiate between reinfection and relapse.
Recurrent urinary tract infections (UTIs) are a common clinical problem, particularly in women. Management strategies depend on whether the episodes represent reinfection or relapse, as these conditions have distinct etiologies and treatment implications.
Reinfection refers to a new bacterial infection occurring after successful eradication of a prior episode. These infections are often associated with behavioral or anatomical risk factors such as sexual activity, spermicide use, or changes in vaginal flora. When reinfections are infrequent—typically one to two episodes per year—each episode is treated independently with a short course of appropriate antibiotics. In patients with frequent reinfections, prophylactic antibiotic therapy, such as low-dose nitrofurantoin, may be considered.
Relapse, by contrast, occurs when symptoms recur shortly after completing antibiotic therapy and is usually caused by persistence of the same organism. Relapse often indicates an unresolved underlying issue, such as urinary tract obstruction, renal calculi, or chronic bacterial prostatitis in males. These cases warrant further diagnostic evaluation and may require prolonged or alternative antimicrobial therapy.
Nitrofurantoin remains the first-line agent for uncomplicated cystitis due to its favorable resistance profile and minimal impact on intestinal flora.
Comparison of Reinfection and Relapse in UTIs
| Aspect | Reinfection | Relapse |
|---|---|---|
| Underlying Cause | New bacterial exposure, often related to sexual activity or contraceptive use | Persistence of the original organism |
| Timing of Recurrence | Occurs after complete resolution of symptoms | Occurs soon after completion of therapy |
| Treatment Strategy | Treat each episode individually; consider prophylaxis if frequent | Investigate structural or chronic causes; prolonged therapy may be required |
| Frequency | Infrequent (1–2 episodes annually) | Rapid recurrence after treatment |
Discuss the treatment for a pediatric patient with a UTI.
Management of urinary tract infections in pediatric patients is age-dependent and must account for both safety and efficacy. In children between six and twelve years of age, methenamine hippurate may be used as a prophylactic agent for recurrent UTIs, particularly in patients without renal abnormalities. This agent works by generating formaldehyde in acidic urine, thereby inhibiting bacterial growth.
In neonates and infants younger than six months, empirical therapy typically consists of intravenous ampicillin combined with gentamicin. This regimen provides broad-spectrum coverage against common neonatal uropathogens while maintaining an acceptable safety profile. Early diagnosis and treatment are critical in this population to prevent renal scarring and long-term complications.
Discuss the specific treatment for patients with enterococcal endocarditis.
Enterococcal endocarditis presents a therapeutic challenge due to the intrinsic resistance of Enterococcus species to many antibiotics. Monotherapy is often insufficient to eradicate the organism, particularly in infections involving cardiac valves.
The standard treatment approach involves combination therapy to achieve synergistic bactericidal activity. A penicillin-class antibiotic, such as ampicillin or penicillin G, is administered alongside an aminoglycoside, most commonly gentamicin. This combination enhances bacterial killing and improves clinical outcomes. Treatment duration is typically prolonged, reflecting the severity and complexity of the infection.
How is gonorrhea treated?
Gonorrhea, caused by Neisseria gonorrhoeae, requires prompt and effective antimicrobial therapy due to rising resistance patterns. Current treatment guidelines recommend cephalosporins as the cornerstone of therapy, given their strong activity against resistant strains.
Third-generation cephalosporins are particularly effective and are used to prevent complications such as pelvic inflammatory disease, infertility, and disseminated gonococcal infection. Adherence to guideline-based therapy is essential to limit further antimicrobial resistance.
What is epinephrine used for? What is the mechanism of action?
Epinephrine is a nonselective adrenergic agonist that stimulates both alpha (α₁, α₂) and beta (β₁, β₂) adrenergic receptors. It does not exert activity on dopamine receptors. Epinephrine is most commonly used in emergency settings, including anaphylaxis, cardiac arrest, and severe asthma exacerbations.
Its mechanism of action involves α₁-mediated vasoconstriction, which increases blood pressure and reduces mucosal edema, and β₂-mediated bronchodilation, which improves airflow. Additionally, β₁ receptor stimulation enhances cardiac contractility and heart rate, thereby increasing cardiac output. These combined effects make epinephrine a life-saving intervention in acute hypersensitivity reactions.
Which allergy medication is best for children? What are the side effects?
Antihistamines are commonly used to manage allergic symptoms in pediatric patients and can be safely administered when dosed according to age and weight. Second-generation antihistamines are often preferred due to their reduced sedative effects.
The adverse effects observed in children are similar to those seen in adults and may include drowsiness, dizziness, impaired coordination, fatigue, gastrointestinal upset, and confusion. Importantly, promethazine is contraindicated in children under two years of age due to the risk of fatal respiratory depression and should not be prescribed in this population.
What should the healthcare provider look for when discontinuing gout medications?
When discontinuing pharmacologic therapy for gout, healthcare providers must closely monitor patients for early signs of adverse drug reactions, as prompt recognition is critical for patient safety.
Colchicine should be discontinued immediately if gastrointestinal symptoms such as severe diarrhea, vomiting, or abdominal pain occur, as these may signal toxicity. Allopurinol must be stopped at the first indication of rash, fever, or systemic symptoms, which may represent a potentially life-threatening hypersensitivity reaction. Early intervention can prevent progression to severe cutaneous or systemic complications.
References
American Academy of Pediatrics Committee on Infectious Diseases. (2019). Red Book: 2018–2021 report of the Committee on Infectious Diseases. American Academy of Pediatrics.
Brunton, L. L., Hilal-Dandan, R., & Knollmann, B. C. (2018). Goodman & Gilman’s the pharmacological basis of therapeutics (13th ed.). McGraw-Hill Education.
Katzung, B. G., Masters, S. B., & Trevor, A. J. (2022). Basic and clinical pharmacology (15th ed.). McGraw-Hill Education.
D116 Unit 8 Study Guide
Mandell, G. L., Bennett, J. E., & Dolin, R. (2020). Principles and practice of infectious diseases (9th ed.). Elsevier.